The Latest

  • Toll Brothers, Inc. (TOL) Receives ‘Outperform’ Upgrade and Price Target of $161

    ·

    Toll Brothers, Inc. (TOL) Receives ‘Outperform’ Upgrade and Price Target of $161

  • Nuvalent, Inc. (NUVL) Receives Equal-Weight Rating from Wells Fargo: What Investors Should Know

    ·

    Nuvalent, Inc. (NUVL) Receives Equal-Weight Rating from Wells Fargo: What Investors Should Know

  • Lennar Corporation (LEN) Downgraded to Underperform: What Investors Need to Know

    ·

    Lennar Corporation (LEN) Downgraded to Underperform: What Investors Need to Know

  • West Pharmaceutical Services, Inc. (WST) Receives Overweight Rating from Barclays, Offers Upside Potential

    ·

    West Pharmaceutical Services, Inc. (WST) Receives Overweight Rating from Barclays, Offers Upside Potential